Fellowship · Houston, TX
Sponsored by Baylor College of Medicine
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
The New England journal of medicine · 2024 · 257 citations · John Moore Vierling
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
The New England journal of medicine · 2024 · 236 citations · John Moore Vierling
Primary biliary cholangitis.
Lancet (London, England) · 2024 · 139 citations · John Moore Vierling
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Journal of hepatology · 2023 · 137 citations · John Moore Vierling
American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations.
Gastrointestinal endoscopy · 2023 · 117 citations · Mohamed Othman
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial.
Nature medicine · 2023 · 156 citations · John Moore Vierling
Endoscopic Submucosal Dissection in North America: A Large Prospective Multicenter Study.
Gastroenterology · 2021 · 165 citations · Mohamed Othman
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.
Journal of hepatology · 2022 · 160 citations · John Moore Vierling